Cannell Capital - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell Capital ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$296,932
-12.9%
74,7940.0%0.07%
+1.5%
Q2 2023$341,061
-13.1%
74,7940.0%0.07%
-10.5%
Q1 2023$392,668
+7.0%
74,7940.0%0.08%
+2.7%
Q4 2022$366,842
-36.2%
74,794
-16.2%
0.07%
-43.9%
Q3 2022$575,000
+1.6%
89,2110.0%0.13%
+15.8%
Q2 2022$566,000
+4.8%
89,211
+13.9%
0.11%
+39.0%
Q1 2022$540,000
+8.4%
78,306
+10.3%
0.08%
+3.8%
Q4 2021$498,00071,0000.08%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$218,2630.12%
Cannell Capital 74,794$366,8420.07%
SANTA MONICA PARTNERS LP 20,000$980.07%
RBF Capital, LLC 144,231$707,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 257,795$1,264,4050.03%
Ancora Advisors LLC 70,916$3480.01%
WEDBUSH SECURITIES INC 30,928$1520.01%
Renaissance Technologies 290,463$1,4250.00%
GEODE CAPITAL MANAGEMENT, LLC 35,206$1730.00%
NORTHERN TRUST CORP 17,030$83,5270.00%
View complete list of PSYCHEMEDICS CORP shareholders